Parallel drug systems: framework and methods based on large language models and three types of humans

LIN Fei; WANG Fei-Yue; TIAN Yonglin; DING Xianting; NI Qinghua; WANG Jing; SHEN Le

doi:10.11959/j.issn.2096-6652.202409

您当前的位置：

首页 >

文章列表页 >

Parallel drug systems: framework and methods based on large language models and three types of humans

Papers and Reports | 更新时间：2024-06-05

- Parallel drug systems: framework and methods based on large language models and three types of humans
- Chinese Journal of Intelligent Science and Technology Vol. 6, Issue 1, Pages: 88-99(2024)
- 作者机构：
  
  1.澳门科技大学创新工程学院工程科学系，澳门 999078
  2.中国科学院自动化研究所复杂系统管理与控制国家重点实验室，北京 100190
  3.中国科学院大学人工智能学院，北京 100049
  4.上海交通大学生物医学工程学院，个性化医学研究院，上海 200030
  5.青岛智能产业技术研究院，山东青岛 266109
  6.中国医学科学院北京协和医院麻醉科，北京 100730
- 作者简介：
- 基金信息：
  
  The National Natural Science Foundation of China(61533019);The Science and Technology Development Fund of Macau Special Administrative Region(0093/2023/RIA2)
- DOI：10.11959/j.issn.2096-6652.202409
  CLC： TP399
- Received：16 January 2024，
  
  Revised：2024-02-26，
  
  Published：15 March 2024
- 稿件说明：
移动端阅览
LIN Fei, WANG Fei-Yue, TIAN Yonglin, et al. Parallel drug systems: framework and methods based on large language models and three types of humans[J]. Chinese Journal of Intelligent Science and Technology, 2024, 6(1): 88-99.
DOI：

LIN Fei, WANG Fei-Yue, TIAN Yonglin, et al. Parallel drug systems: framework and methods based on large language models and three types of humans[J]. Chinese Journal of Intelligent Science and Technology, 2024, 6(1): 88-99. DOI： 10.11959/j.issn.2096-6652.202409.

摘要

近年来，随着物联网、大语言模型、多模态交互等新一代人工智能技术的迅猛发展，传统的药物研发、生产加工等过程面临着智能化转型的挑战。为此，以平行智能为理念，基于ACP方法和大语言模型提出了虚实交互的平行药物系统，并将三类人（数字人、机器人和生物人）的概念引入系统中，详细阐述了该系统的理论框架与构建方法。平行药物系统涵盖医药产业的全流程，药物研发阶段考虑了药物发现、实验室研究、临床试验等过程；药物生产加工阶段考虑了制药工厂运行、系统分析预测等方面；药物医疗保健阶段考虑了个性化用药咨询、增强现实用药指导、隐私安全等内容。平行药物系统打造了一个数字化的“药物空间”，旨在建立药物系统的新范式，推动智能化药物的革命。

Abstract

With the rapid development of the next generation of artificial intelligence technologies

such as the internet of things

large language models

and multimodal interactions

the traditional processes of drug research and production processing had been facing the challenges of an intelligent transition in recent years. In this context

this paper used the theory of parallel intelligence as the research philosophy and proposed a virtual-real interactive parallel drug systems

utilizing the ACP approach and large language models. It incorporated the concept of three types of beings—digital humans

robots

and natural persons—into the systems

providing a detailed discussion on the theoretical underpinnings

construction techniques

and potential application scenarios of the systems. The parallel drug systems covered the entire process of the pharmaceutical industry. For the drug development phase

it considered processes such as drug discovery

laboratory research

and clinical trials. In the production processing phase

it encompassed pharmaceutical manufacturing operations and system analysis predictions. The medical healthcare subsystem included personalized medication consultation

augmented reality drug guidance

and privacy security. The whole systems open up a digitized "drug space"

aiming to establish a new paradigm for the drug systems and propel the revolution of intelligent medication.

关键词

Keywords

references

ZHU Y P. Chinese materia medica: chemistry, pharmacology, and applications[M]. Amsterdam: Harwood Academic, 1998.

MONTINARI M R, MINELLI S, DE CATERINA R. The first 3500 years of aspirin history from its roots - A concise summary[J]. Vascular Pharmacology, 2019, 113: 1-8.

BLAY V, TOLANI B, HO S P, et al. High-Throughput Screening: today's biochemical and cell-based approaches[J]. Drug Discovery Today, 2020, 25(10): 1807-1821.

BORREL A, HUANG R L, SAKAMURU S, et al. High-throughput screening to predict chemical-assay interference[J]. Scientific Reports, 2020, 10(1): 3986.

SOUTO E B, SILVA G F, DIAS-FERREIRA J, et al. Nanopharmaceutics: part I-clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU[J]. Pharmaceutics, 2020, 12(2): 146.

王飞跃. 平行系统方法与复杂系统的管理和控制[J]. 控制与决策, 2004, 19(5): 485-489, 514.

WANG F Y. Parallel system methods for management and control of complex systems[J]. Control and Decision, 2004, 19(5): 485-489, 514.

王飞跃. 平行哲学: 智能产业与智慧经济的本源及其目标[J]. 中国科学院院刊, 2021, 36(3): 308-318.

WANG F Y. Parallel philosophy: origin and goal of intelligent industries and smart economics[J]. Bulletin of Chinese Academy of Sciences, 2021, 36(3): 308-318.

王飞跃. 平行哲学与智能技术: 平行产业与智慧社会的对偶方程与测试基础[J]. 智能科学与技术学报, 2021, 3(3): 245-255.

WANG F Y. Parallel philosophy and intelligent technology: dual equations and testing systems for parallel industries and smart societies[J]. Chinese Journal of Intelligent Science and Technology, 2021, 3(3): 245-255.

王飞跃, 杨柳青, 胡晓娅, 等. 平行网络与网络软件化: 一种新颖的网络架构[J]. 中国科学: 信息科学, 2017, 47(7): 811-831.

WANG F Y, YANG L Q, HU X Y, et al. Parallel networks and network softwarization: a novel network architecture[J]. Scientia Sinica (Informationis), 2017, 47(7): 811-831.

王坤峰, 苟超, 王飞跃. 平行视觉: 基于ACP的智能视觉计算方法[J]. 自动化学报, 2016, 42(10): 1490-1500.

WANG K F, GOU C, WANG F Y. Parallel vision: an ACP-based approach to intelligent vision computing[J]. Acta Automatica Sinica, 2016, 42(10): 1490-1500.

李力, 林懿伦, 曹东璞, 等. 平行学习—机器学习的一个新型理论框架[J]. 自动化学报, 2017, 43(1): 1-8.

LI L, LIN Y L, CAO D P, et al. Parallel learning—a new framework for machine learning[J]. Acta Automatica Sinica, 2017, 43(1): 1-8.

袁勇, 王飞跃. 平行区块链: 概念、方法与内涵解析[J]. 自动化学报, 2017, 43(10): 1703-1712.

YUAN Y, WANG F Y. Parallel blockchain: concept, methods and issues[J]. Acta Automatica Sinica, 2017, 43(10): 1703-1712.

王飞跃. 平行管理: 复杂性管理智能的生态科技与智慧管理之DAO[J]. 自动化学报, 2022, 48(11): 2655-2669.

WANG F Y. Parallel management: the DAO to smart ecological technology for complexity management intelligence[J]. Acta Automatica Sinica, 2022, 48(11): 2655-2669.

王飞跃. 平行哲学与智能科学: 从莱布尼茨的Monad到区块链之DAO[J]. 模式识别与人工智能, 2020, 33(12): 1055-1065.

WANG F Y. Parallel philosophy and intelligent science: from leibniz's monad to blockchain's DAO[J]. Pattern Recognition and Artificial Intelligence, 2020, 33(12): 1055-1065.

ZHANG Y, LUO M Q, WU P, et al. Application of computational biology and artificial intelligence in drug design[J]. International Journal of Molecular Sciences, 2022, 23(21): 13568.

JUMPER J, EVANS R, PRITZEL A, et al. Highly accurate protein structure prediction with AlphaFold[J]. Nature, 2021, 596(7873): 583-589.

VARADI M, ANYANGO S, DESHPANDE M, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models[J]. Nucleic Acids Research, 2022, 50(D1): D439-D444.

HIGH R. The era of cognitive systems: An inside look at IBM Watson and how it works[J]. IBM Redbooks, 2012, 1: 16.

WALLACH I, DZAMBA M, HEIFETS A. AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery[EB]. arXiv preprint, 2015, arXiv: 1510.02855.

BORDUKOVA M, MAKAROV N, RODRIGUEZ-ESTEBAN R, et al. Generative artificial intelligence empowers digital twins in drug discovery and clinical trials[J]. Expert Opinion on Drug Discovery, 2024, 19(1): 33-42.

LOTFOLLAHI M, WOLF F A, THEIS F J. scGen predicts single-cell perturbation responses[J]. Nature Methods, 2019, 16(8): 715-721.

CUI H, WANG C, MAAN H, et al. Scgpt: towards building a foundation model for single-cell multi-omics using generative ai. Nat Methods (2024), accepted, doi: 10.1038/s 41592-024-02201-0.

ANDREINI P, BONECHI S, BIANCHINI M, et al. Image generation by GAN and style transfer for agar plate image segmentation[J]. Computer Methods and Programs in Biomedicine, 2020, 184: 105268.

TANG Y X, ZHANG J L, HE D D, et al. GANDA: a deep generative adversarial network conditionally generates intratumoral nanoparticles distribution pixels-to-pixels[J]. Journal of Controlled Release, 2021, 336: 336-343.

CHEN X, ROBERTS R, LIU Z C, et al. A generative adversarial network model alternative to animal studies for clinical pathology assessment[J]. Nature Communications, 2023, 14: 7141.

ALLEN A, SIEFKAS A, PELLEGRINI E, et al. A digital twins machine learning model for forecasting disease progression in stroke patients[J]. Applied Sciences, 2021, 11(12): 5576.

ARMENI P, POLAT I, DE ROSSI L M, et al. Digital twins in healthcare: is it the beginning of a new era of evidence-based medicine? A critical review[J]. Journal of Personalized Medicine, 2022, 12(8): 1255.

BERTOLINI D, LOUKIANOV A D, SMITH A M, et al. Modeling disease progression in mild cognitive impairment and Alzheimer's disease with digital twins[EB]. arXiv preprint, 2020, arXiv: 2012.13455.

TAYLOR D. The pharmaceutical industry and the future of drug development[M]. London: The Royal Society of Chemistry, 2015: 1-33.

SHARMA N, LIU Y A. A hybrid science-guided machine learning approach for modeling chemical processes: a review[J]. AIChE Journal, 2022, 68(5): e17609.

NASIRIFAR R, SHAFEGHATI S, VALIPOUR I. A new methodology in generating Digital Plants in AVEVA PDMS from Navisworks® model[J]. Journal of Project Management, 2019, 4(4): 257-266.

ARDEN N S, FISHER A C, TYNER K, et al. Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future[J]. International Journal of Pharmaceutics, 2021, 602: 120554.

CHEN Y J, YANG O, SAMPAT C, et al. Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review[J]. Processes, 2020, 8(9): 1088.

MESKÓ B, TOPOL E J. The imperative for regulatory oversight of large language models (or generative AI) in healthcare[J]. NPJ Digital Medicine, 2023, 6(1): 120.

NASHWAN A J, ABUJABER A A. Harnessing the power of large language models (LLMs) for electronic health records (EHRs) optimization[J]. Cureus, 2023, 15(7): e42634.

TU T, AZIZI S, DRIESS D, et al. Towards generalist biomedical AI[J]. NEJM AI, 2024, 1(3): AIoa2300138.

MOOR M, BANERJEE O, ABAD Z S H, et al. Foundation models for generalist medical artificial intelligence[J]. Nature, 2023, 616(7956): 259-265.

TOPOL E J. High-performance medicine: the convergence of human and artificial intelligence[J]. Nature Medicine, 2019, 25(1): 44-56.

ACOSTA J N, FALCONE G J, RAJPURKAR P, et al. Multimodal biomedical AI[J]. Nature Medicine, 2022, 28(9): 1773-1784.

TOVINO S A. The HIPAA privacy rule and the EU GDPR: illustrative comparisons[J]. Seton Hall L. Rev., 2016, 47: 973.

NEWAZ A I, SIKDER A K, RAHMAN M A, et al. A survey on security and privacy issues in modern healthcare systems: attacks and defenses[J]. ACM Transactions on Computing for Healthcare, 2(3): 27.

白天翔, 沈震, 刘雅婷, 等. 平行机器: 一种智能机器的管理与控制框架[J]. 智能科学与技术学报, 2019, 1(2): 181-191.

BAI T X, SHE N Z, LIU Y T, et al. Parallel machine: a framework for the control and management for intelligent machines[J]. Chinese Journal of Intelligent Science and Technology, 2019, 1(2): 181-191.

张俊, 许沛东, 王飞跃. 平行系统和数字孪生的一种数据驱动形式表示及计算框架[J]. 自动化学报, 2020, 46(7): 1346-1356.

ZHANG J, XU P D, WANG F Y. Parallel systems and digital twins: a data-driven mathematical representation and computational framework[J]. Acta Automatica Sinica, 2020, 46(7): 1346-1356.

杨林瑶, 陈思远, 王晓, 等. 数字孪生与平行系统: 发展现状、对比及展望[J]. 自动化学报, 2019, 45(11): 2001-2031.

YANG L Y, CHEN S Y, WANG X, et al. Digital twins and parallel systems: state of the art, comparisons and prospect[J]. Acta Automatica Sinica, 2019, 45(11): 2001-2031.

薛霄, 于湘凝, 周德雨, 等. 计算实验方法的溯源、现状与展望[J]. 自动化学报, 2023, 49(2): 246-271.

XUE X, YU X N, ZHOU D Y, et al. Computational experiments: past, present and perspective[J]. Acta Automatica Sinica, 2023, 49(2): 246-271.

WANG F Y. Toward a revolution in transportation operations: AI for complex systems[J]. IEEE Intelligent Systems, 2008, 23(6): 8-13.

YANG J, WANG X, TIAN Y L, et al. Parallel intelligence in CPSSs: being, becoming, and believing[J]. IEEE Intelligent Systems, 2023, 38(6): 75-80.

MIAO Q H, LYU Y S, HUANG M, et al. Parallel learning: overview and perspective for computational learning across Syn2Real and Sim2Real[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(3): 603-631.

王飞跃, 李乐飞, 黄星, 等. 关于长周期连续安全节能有效生产基础理论的探讨[J]. 计算机与应用化学, 2007, 24(12): 1711-1713.

WANG F Y, LI L F, HUANG X, et al. A discussion of fundamental theory of long period continuous production emphasizing effectiveness, safety and energy saving[J]. Computers and Applied Chemistry, 2007, 24(12): 1711-1713.

熊刚, 王飞跃, 邹余敏, 等. 提升乙烯长周期生产管理的平行评估方法[J]. 控制工程, 2010, 17(3): 401-406.

XIONG G, WANG F Y, ZOU Y M, et al. Parallel evaluation method to improve long period ethylene production management[J]. Control Engineering of China, 2010, 17(3): 401-406.

WANG F Y, YANG J, WANG X X, et al. Chat with ChatGPT on industry 5.0: learning and decision-making for intelligent industries[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(4): 831-834.

WANG F Y. New control paradigm for industry 5.0: From big models to foundation control and management[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(8): 1643-1646.

WANG X X, YANG J, WANG Y T, et al. Steps toward industry 5.0: building "6S" parallel industries with cyber-physical-social intelligence[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(8): 1692-1703.

WANG F Y, MIAO Q H, LI L X, et al. When does sora show: the beginning of TAO to imaginative intelligence and scenarios engineering[J]. CAA Journal of Automatica Sinica, 2024, 11(4): 809-815.

ZHENG Q H, LI Y, CHEN P, et al. An innovative IPFS-based storage model for blockchain[C]//Proceedings of the 2018 IEEE/WIC/ACM International Conference on Web Intelligence (WI). Piscataway: IEEE Press, 2018: 704-708.

XUE X, YU X N, WANG F Y. ChatGPT chats on computational experiments: from interactive intelligence to imaginative intelligence for design of artificial societies and optimization of foundational models[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(6): 1357-1360.

LIU S C, WANG J X, YANG Y J, et al. ChatGPT-powered conversational drug editing using retrieval and domain feedback[EB]. arXiv preprint, 2023, arXiv: 2305.18090.

MIAO Q H, ZHENG W B, LV Y S, et al. DAO to HANOI via DeSci: AI paradigm shifts from AlphaGo to ChatGPT[J]. IEEE/CAA Journal of Automatica Sinica, 2023, 10(4): 877-897.

王飞跃. 平行医生与平行医院: ChatGPT与通用人工智能技术对未来医疗的冲击与展望[J]. 协和医学杂志, 2023, 14(4): 673-679.

WANG F Y. Parallel doctors and parallel hospitals: impact and perspective of ChatGPT-like AIGC and AGI on medicine and medicare[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 673-679.

王飞跃. 数字医生与平行医疗: 从医疗知识自动化到系统化智能医学[J]. 协和医学杂志, 2021, 12(6): 829-833.

WANG F Y. Digital doctors and parallel medicare: from medical knowledge automation to systems intelligence medicine. Medical Journal of Peking Union Medical College Hospital, 2021,12(6): 829-833.

WANG F Y, WONG P K. Intelligent systems and technology for integrative and predictive medicine: an ACP approach[J]. ACM Transactions on Intelligent Systems and Technology, 2013, 4(2): 32.

王飞跃. 平行药物与智能药学[R]. QAII技术报告, 2014.

WANG F Y. Parallel drugs and smart pharmacy[R]. QAII Technical Report, 2014.

王飞跃, 张梅, 孟祥冰, 等. 平行眼: 基于ACP的智能眼科诊疗[J]. 模式识别与人工智能, 2018, 31(6): 495-504.

WANG F Y, ZHANG M, MENG X B, et al. Parallel eyes: an ACP-based smart ophthalmic diagnosis and treatment[J]. Pattern Recognition and Artificial Intelligence, 2018, 31(6): 495-504.

王飞跃, 苟超, 王建功, 等. 平行皮肤: 基于视觉的皮肤病分析框架[J]. 模式识别与人工智能, 2019, 32(7): 577-588.

WANG F Y, GOU C, WANG J G, et al. Parallel skin: a vision-based dermatological analysis framework[J]. Pattern Recognition and Artificial Intelligence, 2019, 32(7): 577-588.

张梅, 陈鸰, 王飞跃, 等. 平行胃肠: 基于ACP的智能胃肠疾病诊疗[J]. 模式识别与人工智能, 2019, 32(12): 1061-1071.

ZHANG M, CHEN L, WANG F Y, et al. Parallel gastrointestine: an ACP-based approach for intelligent operations[J]. Pattern Recognition and Artificial Intelligence, 2019, 32(12): 1061-1071.

王飞跃, 张梅, 孟祥冰, 等. 平行手术: 基于ACP的智能手术计算方法[J]. 模式识别与人工智能, 2017, 30(11): 961-970.

WANG F Y, ZHANG M, MENG X B, et al. Parallel surgery: an ACP-based approach for intelligent operations[J]. Pattern Recognition and Artificial Intelligence, 2017, 30(11): 961-970.

赵毅飞, 申乐, 叶佩军, 等. 平行麻醉:从麻醉自动化走向智慧型全周期麻醉平台[J]. 智能科学与技术学报, 2023, 5(2): 234-246.

ZHAO Y F, SHEN L, YE P J, et al. Parallel anesthesia: from anesthesia automation to intelligent full-cycle anesthesia platform[J]. Chinese Journal of Intelligent Science and Technology, 2023, 5(2): 234-246.

王飞跃. 平行医学:从医学的温度到智慧的医学[J]. 智能科学与技术学报, 2021, 3(1): 1-9.

WANG F Y. Parallel medicine: from warmness of medicare to medicine of smartness[J]. Chinese Journal of Intelligent Science and Technology, 2021, 3(1): 1-9.

王拥军, 王飞跃, 王戈, 等. 平行医院: 从医院信息管理系统到智慧医院操作系统[J]. 自动化学报, 2021, 47(11): 2585-2599.

WANG Y J, WANG F Y, WANG G, et al. Parallel hospitals: from hospital information system(HIS) to hospital smart operating system(HSOS)[J]. Acta Automatica Sinica, 2021, 47(11): 2585-2599.

CHAKRABORTY C, BHATTACHARYA M, LEE S S. Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development[J]. Molecular Therapy Nucleic Acids, 2023, 33: 866-868.

SAVAGE N. Drug discovery companies are customizing ChatGPT: here's how[J]. Nature Biotechnology, 2023, 41(5): 585-586.

JUHI A, PIPIL N, SANTRA S, et al. The capability of ChatGPT in predicting and explaining common drug-drug interactions[J]. Cureus, 2023, 15(3): e36272.

LIANG Y, ZHANG R, ZHANG L, et al. DrugChat: towards enabling ChatGPT-like capabilities on drug molecule graphs[J]. arXiv preprint, 2023, arXiv: 2309.03907.

田永林, 王雨桐, 王建功, 等. 视觉 Transformer 研究的关键问题: 现状及展望[J]. 自动化学报, 2022, 48(4): 957-979.

TIAN Y L, WANG Y T, WANG J G, et al. Key problems and progress of vision Transformers: The state of the art and prospects. Acta Automatica Sinica, 2022, 48(4): 957-979.

田永林, 陈苑文, 杨静, 等. 元宇宙与平行系统: 发展现状, 对比及展望[J]. Chinese Journal of Intelligent Science & Technology, 2023, 5(1): 121-132.

TIAN Y L, CHEN Y W, YANG J, et al. Metaverses and parallel systems: the state of the art, comparisons and prospects[J]. Chinese Journal of Intelligent Science and Technology, 2023, 5(1): 121-132.

QURESHI R, IRFAN M, GONDAL T M, et al. AI in drug discovery and its clinical relevance[J]. Heliyon, 2023, 9(7): e17575.

王飞跃, 王艳芬, 陈薏竹, 等. 联邦生态: 从联邦数据到联邦智能[J]. 智能科学与技术学报, 2020, 2(4): 305-311.

WANG F Y, WANG Y F, CHEN Y Z, et al. Federated ecology: from federated data to federated intelligence[J]. Chinese Journal of Intelligent Science and Technology, 2020, 2(4): 305-311.

HO J, JAIN A, ABBEEL P. Denoising diffusion probabilistic models[J]. Advances in neural information processing systems, 2020, 33: 6840-6851.

NING Y L, TEIXAYAVONG S, SHANG Y Q, et al. Generative artificial intelligence in healthcare: ethical considerations and assessment checklist[EB]. arXiv preprint, 2023, arXiv: 2311.02107.

丁显廷, 王飞跃. 平行药物[R]. 上海交通大学, 2018.

DING X T, WANG F Y. Parallel drugs [R]. Shanghai Jiao Tong University, 2018.

WANG B, DING X, WANG F Y. Determination of polynomial degree in the regression of drug combinations[J]. IEEE/CAA Journal of Automatica Sinica, 2017, 4(1): 41-47.

Views

618

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Parallel teaching laboratories: a new AI infrastructure empowering K-12 education

Parallel Macao field observatory: autonomous systems for global intelligent observation and emergency management

Parallel battery: the framework and process for an intelligent and ecological battery system and related services

Parallel transportation:virtual-real interaction for intelligent traffic management and control

Cerberus: a cross-site social bot detection system based on deep learning

Related Author

Gao Xin

Lin Fei

Fu Jun

Sun Jianjun

Huang Jun

Joseph Hun-Wei Lee

Ni Qinghua

Lin Fei

Related Institution

Tianjin No. 2 High School

Department of Engineering Science, Faculty of Innovation Engineering, Macau University of Science and Technology, Macao

Environmental Research Institute, Macau University of Science and Technology, Macao

State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation,Chinese Academy of Sciences

DeSci Center of Parallel Intelligence, Óbuda University

Postal code：100079
Tel：（010）53879206 Email：cjist@bjxintong.com.cn
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：162003 Visits Today：166

⁰